Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup

NCT02858193 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchitis

Interventions

DRUG: SCMC-lys powder 1.35 g
DRUG: Fluifort® syrup

Sponsor

Dompé Farmaceutici S.p.A

Collaborators

[object Object]